Search Results - "Muri, Estela Maris F."

Statine-based peptidomimetic compounds as inhibitors for SARS-CoV-2 main protease (SARS-CoV‑2 Mpro) by Azevedo, Pedro Henrique R. de A., Camargo, Priscila G., Constant, Larissa E. C., Costa, Stephany da S., Silva, Celimar Sinézia, Rosa, Alice S., Souza, Daniel D. C., Tucci, Amanda R., Ferreira, Vivian N. S., Oliveira, Thamara Kelcya F., Borba, Nathalia R. R., Rodrigues, Carlos R., Albuquerque, Magaly G., Dias, Luiza R. S., Garrett, Rafael, Miranda, Milene D., Allonso, Diego, Lima, Camilo Henrique da S., Muri, Estela Maris F.

“…COVID-19 is a multisystemic disease caused by the SARS-CoV-2 airborne virus, a member of the Coronaviridae family. It has a positive sense single-stranded RNA…”
Get full text

Putative Inhibitor of TcCYP51 from a Library of Approved Drugs: A Virtual Screening Study by Flores-Junior, Luiz Augusto, dos Santos, Eldio, Muri, Estela Maris, Lima, Camilo Henrique, Dias, Luiza Rosaria

“…Chagas disease is a public health problem, particularly in Latin America. The available treatment consists of two poorly effective drugs in the chronic phase…”
Get full text

Design and Synthesis of Heterocyclic Hydroxamic Acid Derivatives as Inhibitors of Helicobacter pylori Urease by Muri, Estela Maris F., Mishra, Hetal, Avery, Mitchell A., Williamson, John S.

“…Helicobacter pylori produces ammonia to help counter the acidic environment in the human stomach. The production of ammonia, essential for the microorganism's…”
Get full text